Drug info - Interdose elevation in plasma cortisol during chronic treatment with alprazolam but not lorazepam in the elderly (2004) - Drugs Forum
Drugs-Forum  
News Groups Blog Forum Chat Video Audio Images Documents Wiki Home
Go Back   Drugs Forum > CHEMICAL & (SEMI-) SYNTHETIC DRUGS > Downers and sleeping pills > Benzodiazepines
Register Tags Mark Forums Read

Notices

Benzodiazepines All about benzodiazepines (downers)

Reply
 
Thread Tools Display Modes
  #1  
Old 08-03-2008, 17:53
Jatelka's Avatar
Jatelka Jatelka is offline
Jatelka is back in a funk: The weekend aint so great!
Psychedelic Shepherdess
Moderator
 
Join Date: 16-10-2005
Location: United Kingdom
Age: 33
Posts: 5,025
Jatelka is a true resource and beyond reputeJatelka is a true resource and beyond reputeJatelka is a true resource and beyond reputeJatelka is a true resource and beyond reputeJatelka is a true resource and beyond reputeJatelka is a true resource and beyond reputeJatelka is a true resource and beyond reputeJatelka is a true resource and beyond reputeJatelka is a true resource and beyond reputeJatelka is a true resource and beyond reputeJatelka is a true resource and beyond repute
Points: 18,312, Level: 19 Points: 18,312, Level: 19 Points: 18,312, Level: 19
Activity: 0% Activity: 0% Activity: 0%
Interdose elevation in plasma cortisol during chronic treatment with alprazolam but not lorazepam in the elderly (2004)

A new entry has been added to Drugs Archive

Description:
Neuropsychopharmacology. 2004 Mar;29(3):605-11.

Pomara N, Willoughby LM, Ritchie JC, Sidtis JJ, Greenblatt DJ, Nemeroff CB.

Benzodiazepines (BZPs) have been shown to reduce hypothalamic-pituitary-adrenal (HPA) axis activity acutely in normal humans. In contrast, the effects of chronic BZP treatment on the HPA axis have not been well studied, especially in the geriatric population. This study examined the acute and chronic effects (3 weeks) of alprazolam and lorazepam on plasma cortisol in 68 subjects (60-83 years) who received 0.25 or 0.50 mg b.i.d. alprazolam, or 0.50 or 1.0 mg b.i.d. lorazepam, or placebo orally according to a randomized, double-blind, placebo-controlled parallel design. Memory assessment and blood samples for plasma cortisol were obtained prior to the morning dose on days 0, 7, 14, and 21, and at 1, 2.5, and 5 h postdrug on days 0 and 21. Assessments of anxiety and depression were carried out at days 0, 7, 14, and 21 before drug administration. Plasma cortisol was affected compared to placebo only by the 0.5 mg alprazolam dose. During the first and the last day of treatment, there was a significant drop in cortisol at 2.5 h after alprazolam compared to placebo. The predose cortisol levels increased significantly during chronic alprazolam treatment, and correlations were found between these cortisol changes and changes in depression, anxiety, and memory scores. These findings suggest that even a short period of chronic treatment with alprazolam, but not lorazepam, may result in interdose HPA axis activation in the elderly, consistent with drug withdrawal. If confirmed, this effect may contribute to an increased risk for drug escalation and dependence during chronic alprazolam treatment.

To check it out, rate it or add comments, visit Interdose elevation in plasma cortisol during chronic treatment with alprazolam but not lorazepam in the elderly (2004)
The comments you make there will appear in the posts below.
Reply With Quote
Reply

Bookmarks

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
Interesting scholarly drug facts rxbandit Pharmacology 17 30-10-2008 06:53
Drug info - Sex-related elevation in cortisol during chronic treatment with alprazolam associated with enhanced cognitive performance (2005) Jatelka Benzodiazepines 0 08-03-2008 17:33


Sitelinks: Site Functions:

All times are GMT +1. The time now is 01:58.


Copyright: Substance Information Network 2003 - 2009, All rights reserved